Aclairo Pharmaceutical Development Group Inc Vienna, VA - 22182

Aclairo Pharmaceutical Development Group Inc is categorized under in Vienna, VA and active since 2009.

Aclairo Pharmaceutical Development Group Inc was established in 2009, and today employs 1 to 4, earning $100.000 to $499.999 per year. This is a business, which does work in the B2C market, and is classified as a , under code number 446110 by the NAICS.

If you are seeking more information, feel free to contact Cynthia Smith at the company’s single location by writing to 8230 Leesburg Pike # 620, Vienna, Virginia VA 22182 or by phoning (703) 506-6760. You can also visit this business on Facebook by going to their profile page at Facebook or on find them on Twitter.

Business Name: Aclairo Pharmaceutical Development Group Inc
Contact Person: Cynthia Smith
Address: 8230 Leesburg Pike # 620, Vienna, Virginia 22182
Phone Number: (703) 506-6760
Website Address: aclairo.com
Annual Revenue (USD): $100.000 to $499.999
Founded: 2009
Location Type: Single Location
Employee Number: 1 to 4
Business Type: B2C (Business to Consumer)
Business Category:
SIC Code: 5912
NAICS Code: 446110
Share This Business:

Aclairo Pharmaceutical Development Group Inc was started in 2009 to provide professional under the SIC code 5912 and NAICS code 446110. Since its inception, the company has gone on to take a total of 1 to 4 personnel under its employment and has achieved earnings of $100.000 to $499.999 per annum.

Feel free to contact Cynthia Smith for inquiries that concern Aclairo Pharmaceutical Development Group Inc by calling the company number (703) 506-6760, as your correspondence is most welcome. Additionally, the physical location of the single location of Aclairo Pharmaceutical Development Group Inc can be found at the coordinates 38.917759,-77.229181 as well as the street address 8230 Leesburg Pike # 620 in Vienna, Virginia 22182.

For its online presence, you may visit Aclairo Pharmaceutical Development Group Inc’s website at aclairo.com and engage with its social media outlets through on Twitter and on Facebook.